Brief: Immuneering Reports Q4 And Full Year 2022 Financial Results And Provides Business Updates
06/03/2023 23:40
March 6 (Reuters) - Immuneering Corp IMRX.O :
* IMMUNEERING REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* IMMUNEERING CORP - CASH RUNWAY EXTENDED INTO Q4 2024
* IMMUNEERING CORP - QTRLY LOSS PER SHARE $0.50
Source text for Eikon: ID:nGNXbBkGHx
Further company coverage: IMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences